Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes NEJM September 17, 2015, online first...

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial...